Response to “Excessive Visceral Adipose Tissue Accumulation Increases the Risk of Recurrence and Mortality After Curative Treatment for Metabolic Dysfunction‐Associated Steatotic Liver Disease‐Associated Hepatocellular Carcinoma”

Key Points

• Increased visceral adipose tissue correlates with higher mortality in hepatocellular carcinoma patients, emphasizing the need for monitoring.
• Findings indicate that visceral fat may significantly affect recurrence rates post-treatment, underscoring its role in prognosis.
• Analysis highlights the complex relationship between metabolic dysfunction and liver cancer outcomes, necessitating further investigation.
• Implications call for addressing visceral fat as a potential target in managing hepatocellular carcinoma outcomes.